1Stubbs MT,Bode W.A player of many parts:the spotlight falls on thrombin's structure.Thromb Res,1993,69:1258.
2Hirsh J,Warkentin TE,Raschke R,et al.Heparin and low-molecular-weight heparin.Mechanisms of action,pharmacokinetics,dosing considerations,monitoring,and safety.Chest,1998,114(Suppl):489S-510S.
3Weitz JI,Buller HR.Direct thrombin inhibitors in acute coronary syndromes:present and future.Circulation,2002,105:1004-1011.
4Bates SM,Weitz JI.Direct thrombin inhibitors for treatment of arterial thrombosis:potential differences between bivalirudin and hirudin.Am J Cardiol,1998,82(Suppl):12P-18P.
5Nawarskas JJ,Anderson JR.Bivalirudin:a new approach to anticoagulation.Heart Dis,2001,3:131-137.
6Topol EJ,Bonan R,Jewitt D,et al.Use of a direct antithrombin,Hirulog,in place of heparin during coronary angioplasty.Circulation,1993,87:1622-1629.
7Bittl JA,Strony J,Brinker JA,et al.Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina.N Engl J Med,1995,333:764-769.
8Bittl JA,Chaitman BR,Feit F,et al.Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina:Final report reanalysis of the Bivalirudin Angioplasty Study.Am Heart J,2001,142:952-959.
9Dangas G,Lasic Z,Mehran R,et al.Effectiveness of the concomitant use of bivalirudin and drug-eluting stents (from the prospective,multicenter BivAlirudin and Drug-Eluting STents [ADEST] study).Am J Cardiol,2005,96:659-663.
10Rajagopal V,Lincoff AM,Cohen DJ,et al.Outcomes of patients with acute coronary syndromes who are treated with bivalirudin during percutaneous coronary intervention:an analysis from the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) trial.Am Heart J,2006,152:149-154.
8Andrew P.Selwyn MD.Prothrombotic and antithrombotic pathways in acute coronary syndromes[J].Am J Cardiol 2003,91(12A):3H-11H.
9James E,David E,Cindy L,et al.Benefits and risks of abeiximab use in primary angiopalasty for acute myocaniial infarction[J].Circulation,2003,108(11):1316.
